ahlam1399
09-07-2016, 12:52 AM
Allergan vows limited price hikes, says ?outliers? deter research
(Reuters) – The chief executive ******r of Allergan Plc said his company would limit annual price increases on its prescription *****, and that “outlier” drugmakers that have imposed huge price increases on their products were scaring off venture capital investors.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=WToY7AYv_w4:vz5p5stqyKs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=WToY7AYv_w4:vz5p5stqyKs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=WToY7AYv_w4:vz5p5stqyKs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=WToY7AYv_w4:vz5p5stqyKs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=WToY7AYv_w4:vz5p5stqyKs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/WToY7AYv_w4
(Reuters) – The chief executive ******r of Allergan Plc said his company would limit annual price increases on its prescription *****, and that “outlier” drugmakers that have imposed huge price increases on their products were scaring off venture capital investors.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=WToY7AYv_w4:vz5p5stqyKs:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=WToY7AYv_w4:vz5p5stqyKs:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=WToY7AYv_w4:vz5p5stqyKs:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=WToY7AYv_w4:vz5p5stqyKs:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=WToY7AYv_w4:vz5p5stqyKs:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/WToY7AYv_w4